US5670633A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sugar modified oligonucleotides that detect and modulate gene expression
Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1991-08-12
•
Granted: 1997-09-23
•
Expires: 2011-08-12
Abstract
Abstract Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least two of the 2'-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of HIV, herpes virus, papillomavirus and other infections is provided.
Inventors
- 👤 Phillip Dan Cook
- 👤 Andrew Mamoro Kawasaki
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 11:58
CPC Classifications
A; A61; A61K; A61K48/00; A61P; A61P31/00; A61P31/12; A61P43/00; C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16; C07H19/20; C07H21/00; C07H23/00; C07J; C07J43/00; C07J43/003; C07K; C07K14/00; C07K14/005; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C12N15/1137; C12N9/00; C12N9/0004; C12N9/0069; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Y; C12Y113/00; C12Y113/11; C12Y113/11012; A61K38/00; C12N2310/00; C12N2310/30; C12N2310/31; C12N2310/312; C12N2310/3125; C12N2310/315; C12N2310/32; C12N2310/321; C12N2310/322; C12N2310/33; C12N2310/333; C12N2310/336; C12N2310/35; C12N2310/351; C12N2310/3511; C12N2310/352; C12N2310/3521; C12N2310/3523; C12N2310/3527; C12N2310/353; C12N2310/3531; C12N2310/3533; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/16011; C12N2740/16311; C12N2740/16322
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
116 words
An oligonucleotide that hybridizes with RNA or DNA, having 5 to 50 covalently-bound nucleosides that individually include a ribose or deoxyribose sugar portion and a base portion, wherein: said sugar portions of said nucleosides are joined together by 3'-5' internucleoside linkages such that the base portions of said nucleosides form a mixed base sequence that is complementary to an RNA base sequence or to a DNA base sequence; and at least two of said nucleosides include a modified deoxyfuranosyl moiety bearing a 2'-fluoro substituent; and wherein a duplex formed between said oligonucleotide and its complement exhibits greater thermal stability than does a duplex formed between said complement and an oligonucleotide that does not include 2'-fluoro substituents.
Claim 2
Dependent Claim
116 words
An oligonucleotide that hybridizes with RNA or DNA, having 5 to 50 covalently-bound nucleosides that individually include a ribose or deoxyribose sugar portion and a base portion, wherein: said sugar portions of said nucleosides are joined together by 3'-5' internucleoside linkages such that the base portions of said nucleosides form a mixed base sequence that is complementary to an RNA base sequence or to a DNA base sequence; and at least two of said nucleosides include a modified deoxyfuranosyl moiety bearing a 2'-fluoro substituent; and wherein a duplex formed between said oligonucleotide and its complement exhibits greater thermal stability than does a duplex formed between said complement and an oligonucleotide that does not include 2'-fluoro substituents.
Claim 3
Dependent Claim
14 words
The oligonucleotide of claim 1 wherein said modified deoxyfuranosyl moiety is a 2'-deoxy-2'-fluororibofuranomyl moiety.
Claim 4
Dependent Claim
24 words
The oligonucleotide of claim 1 wherein at least two of said nucleosides are covalently bound through phosphorothioate, methyl phosphonate, or phosphate alkylate internucleoside linkages.
References Cited (Backward Citations)
US4381344A
Cited
US5013830A
Cited
EP0260032A2
Cited
EP0287313A2
Cited
DE3915462A1
Cited
CA2017369A1
Cited
EP0399330A1
Cited
WO1990015814A1
Cited
US5134066A
Cited
EP0417999A1
Cited
WO1991006556A1
Cited
US5466786A
Cited
US5466786B1
Cited
US5212295A
Cited
WO1991015499A1
Cited
WO1992007065A1
Cited
DE4110085A1
Cited
US5214135A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-09-22 | 2001-03-24 | 2001-09-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-09-22 | 2005-03-24 | 2005-09-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-09-22 | 2009-03-24 | 2009-09-23 | $7700.00 | Window Closed / Lapsed |